AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Moberg Pharma

Major Shareholding Notification Sep 18, 2024

3174_iss_2024-09-18_cb4b434b-aedc-45d9-9974-102c055d8f8c.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Moberg Pharma AB (publ)

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
------------
Instrument Aktier
Before the transaction
Shares Data not given
Data not given
Voting rights
Transaction
Reason for major shareholding notification Share loan
Date 17/09/2024
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 2,298,837
Directly held voting rights 0
Indirectly held voting rights 2,298,837
Percentage
Directly held shares 4.80126 %
Directly held voting rights 0 %
Indirectly held voting rights 4.80126 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.80126 % 2,298,837
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled 0.33532 % 160,551
Total 5.13658 % 2,459,388

Group total holdings

Voting rights 2,459,388 Percentage of voting rights 5.13658

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Angivet gränsvärde har underskridits på grund av utlåning av aktier.

Published

18/09/2024 10:25

Contact

Name Marie Karlsfeldt

Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.